For the year ending 2024-12-31, ORGS has $1,351K in assets. $38,884K in debts. $78K in cash and cash equivalents.
| Balance Sheets | 2024-12-31 | |||
|---|---|---|---|---|
| Receivables from related parties | 0 | |||
| Inventory | 0 | |||
| Cash and cash equivalents | 78 | |||
| Restricted cash | 609 | |||
| Prepaid expenses and other receivables | 34 | |||
| Accounts receivable, net of credit losses of december 31, 2024 14,281 (0 as of december 31, 2023) | 40 | |||
| Total current assets | 761 | |||
| Equity investees | 0 | |||
| Intangible assets, net | 0 | |||
| Other assets | 0 | |||
| Goodwill | 0 | |||
| Operating lease right-of-use assets | 0 | |||
| Deposits | 12 | |||
| Subtotal | 13,164 | |||
| Less accumulated depreciation | 12,586 | |||
| Property, plants and equipment, net | 578 | |||
| Total non-current assets | 590 | |||
| Total assets | 1,351 | |||
| Short-term bank credit | 40 | |||
| Accounts payable-Nonrelated Party | 10,428 | |||
| Accounts payable-Related Party | 2,695 | |||
| Accrued expenses and other payables | 2,345 | |||
| Income tax payable | 781 | |||
| Employees and related payables | 2,122 | |||
| Advance payments on account of grant | 72 | |||
| Short-term loans | 6,183 | |||
| Current maturities of finance leases | 25 | |||
| Current maturities of operating leases | 234 | |||
| Short-term and current maturities of convertible loans | 1,995 | |||
| Total current liabilities | 26,920 | |||
| Non-current operating leases | 1,308 | |||
| Loans payable | 2,895 | |||
| Convertible loans | 5,578 | |||
| Finance leases | 1 | |||
| Other long-term liabilities | 2,182 | |||
| Total long-term liabilities | 11,964 | |||
| Total liabilities | 38,884 | |||
| Common stock of 0.0001 par value authorized at december 31, 2024 and december 31, 2023 14,583,333 shares issued at december 31, 2024 and december 31, 2023 5,199,963 and 3,216,363 shares, respectively outstanding at december 31, 2024 and december 31, 2023 5,171,306 and 3,187,706 shares, respectively | 5 | |||
| Additional paid-in capital | 188,163 | |||
| Accumulated other comprehensive income | 384 | |||
| Treasury stock 286,567 shares as of december 31, 2024 and december 31, 2023 | 1,266 | |||
| Accumulated deficit | -224,787 | |||
| Equity attributable to orgenesis inc | -37,501 | |||
| Non-controlling interests | -32 | |||
| Total equity (capital deficiency) | -37,533 | |||
| Total liabilities, redeemable non-controlling interest and equity (capital deficiency) | 1,351 | |||
Orgenesis Inc. (ORGS)
Orgenesis Inc. (ORGS)